Published in AIDS on March 13, 2010
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87
Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One (2010) 3.38
Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLoS Med (2011) 2.76
Combination HIV prevention: significance, challenges, and opportunities. Curr HIV/AIDS Rep (2011) 2.72
Universal testing and treatment as an HIV prevention strategy: research questions and methods. Curr HIV Res (2011) 2.60
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One (2012) 2.39
Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa. PLoS One (2010) 2.30
The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis (2011) 2.20
Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects. Lancet Infect Dis (2013) 2.00
HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS (2012) 1.97
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS (2010) 1.83
Test-and-treat in Los Angeles: a mathematical model of the effects of test-and-treat for the population of men who have sex with men in Los Angeles County. Clin Infect Dis (2013) 1.77
Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS (2012) 1.73
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med (2013) 1.73
Who gets tested for HIV in a South African urban township? Implications for test and treat and gender-based prevention interventions. J Acquir Immune Defic Syndr (2011) 1.67
The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa. PLoS One (2011) 1.67
Will circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventions. Sex Transm Infect (2010) 1.60
Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? AIDS (2010) 1.57
Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci U S A (2010) 1.48
HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med (2012) 1.45
Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep (2013) 1.36
Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics. AIDS (2010) 1.34
Challenges of a hidden epidemic: HIV prevention among women in the United States. J Acquir Immune Defic Syndr (2010) 1.27
Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One (2013) 1.26
Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS (2012) 1.26
Plasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infection. PLoS One (2012) 1.22
Early identification of HIV: empirical support for jail-based screening. PLoS One (2012) 1.15
HIV-1 RNA rectal shedding is reduced in men with low plasma HIV-1 RNA viral loads and is not enhanced by sexually transmitted bacterial infections of the rectum. J Infect Dis (2011) 1.15
Increased HIV testing and reduced undiagnosed infection among gay men in Scotland, 2005-8: support for the opt-out testing policy? Sex Transm Infect (2011) 1.14
Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence. Proc Natl Acad Sci U S A (2014) 1.13
HIV prevention research: taking stock and the way forward. AIDS (2010) 1.13
Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care. J Infect Dis (2012) 1.12
Effective HIV prevention: the indispensable role of social science. J Int AIDS Soc (2012) 1.12
Antiretroviral therapy: a promising HIV prevention strategy? J Acquir Immune Defic Syndr (2010) 1.11
Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as prevention. J Acquir Immune Defic Syndr (2013) 1.11
The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface (2012) 1.10
Treatment as prevention: preparing the way. J Int AIDS Soc (2011) 1.09
Universal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costs. PLoS One (2012) 1.08
Prospects of elimination of HIV with test-and-treat strategy. Proc Natl Acad Sci U S A (2013) 1.08
HIV treatment as prevention: the key to an AIDS-free generation. J Food Drug Anal (2013) 1.05
Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance. Cost Eff Resour Alloc (2013) 1.02
Responding to the National HIV/AIDS Strategy-setting the research agenda. J Acquir Immune Defic Syndr (2011) 1.02
Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis. Antivir Ther (2012) 1.02
Should home-based HIV testing and counseling services be offered periodically in programs of ARV treatment as prevention? A case study in Likoma (Malawi). AIDS Behav (2013) 1.01
Modelling sexual transmission of HIV: testing the assumptions, validating the predictions. Curr Opin HIV AIDS (2010) 1.01
Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr (2012) 0.99
Modelling the impact of antiretroviral therapy on the epidemic of HIV. Curr HIV Res (2011) 0.98
Late entry into HIV care: lessons from Brazil, 2003 to 2006. BMC Infect Dis (2012) 0.98
Estimating the resources required in the roll-out of universal access to antiretroviral treatment in Zimbabwe. Sex Transm Infect (2011) 0.97
Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study. Hum Resour Health (2012) 0.95
Sexual risk behaviors among HIV-infected South African men and women with their partners in a primary care program: implications for couples-based prevention. AIDS Behav (2012) 0.95
Modeling the impact on HIV incidence of combination prevention strategies among men who have sex with men in Beijing, China. PLoS One (2014) 0.93
Operational research to improve HIV prevention in the United States. J Acquir Immune Defic Syndr (2012) 0.91
Adaptation of a U.S. evidence-based Positive Prevention intervention for youth living with HIV/AIDS in Kinshasa, Democratic Republic of the Congo. Eval Program Plann (2012) 0.91
Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review. Am J Public Health (2013) 0.90
Operationalizing treatment as prevention in Los Angeles County: antiretroviral therapy use and factors associated with unsuppressed viral load in the Ryan White system of care. AIDS Patient Care STDS (2012) 0.87
Young, Online and in the Dark: Scaling Up HIV Testing among MSM in ASEAN. PLoS One (2015) 0.86
Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey. Clin Infect Dis (2013) 0.85
Heterogeneous HIV testing preferences in an urban setting in Tanzania: results from a discrete choice experiment. PLoS One (2014) 0.85
Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic. Curr HIV/AIDS Rep (2014) 0.85
Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model. PLoS One (2015) 0.85
The dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling study. Sex Transm Infect (2014) 0.84
Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res (2011) 0.84
Structural approaches for prevention of sexually transmitted HIV in general populations: definitions and an operational approach. J Int AIDS Soc (2014) 0.84
A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial. PLoS Med (2017) 0.83
Contact with HIV prevention services highest in gay and bisexual men at greatest risk: cross-sectional survey in Scotland. BMC Public Health (2010) 0.83
HIV treatment-as-prevention research: taking the right road at the crossroads. PLoS Med (2015) 0.83
What do mathematical models tell us about the emergence and spread of drug-resistant HIV? Curr Opin HIV AIDS (2011) 0.82
The Art of HIV Elimination: Past and Present Science. J AIDS Clin Res (2015) 0.82
CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters. AIDS (2011) 0.82
Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission. PLoS One (2012) 0.82
Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy. Front Immunol (2014) 0.81
Factors associated with utilization of HAART amongst hard-to-reach HIV-infected individuals in Atlanta, Georgia. J AIDS HIV Res (2011) 0.81
How HIV treatment could result in effective prevention. Future Virol (2010) 0.80
Treatment And Prevention for female Sex workers in South Africa: protocol for the TAPS Demonstration Project. BMJ Open (2016) 0.80
'Slipping through the cracks': policy implications of delays in HIV treatment seeking. Glob Public Health (2012) 0.79
High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in Nigeria. BMC Infect Dis (2015) 0.79
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis. Am J Epidemiol (2016) 0.78
HIV testing and engagement in care among highly vulnerable female sex workers: implications for treatment as prevention models. J Health Care Poor Underserved (2014) 0.78
Combining epidemiological and genetic networks signifies the importance of early treatment in HIV-1 transmission. PLoS One (2012) 0.78
Potential impact of multiple interventions on HIV incidence in a hyperendemic region in Western Kenya: a modelling study. BMC Infect Dis (2016) 0.77
Impact of Heterogeneity in Sexual Behavior on Effectiveness in Reducing HIV Transmission with Test-and-Treat Strategy. PLoS Comput Biol (2016) 0.77
Antiretroviral therapy needs: the effect of changing global guidelines. Sex Transm Infect (2010) 0.77
Barriers to Provider-Delivered Sexual Behavior Counseling for Youth Living with HIV/AIDS in the Democratic Republic of the Congo. J HIV AIDS Soc Serv (2013) 0.76
Interaction of mathematical modeling and social and behavioral HIV/AIDS research. Curr Opin HIV AIDS (2011) 0.76
Client-provider interactions in provider-initiated and voluntary HIV counseling and testing services in Uganda. BMC Health Serv Res (2013) 0.76
Correlates of HIV Testing Among Men Who have Sex with Men in Three Urban Areas of Mozambique: Missed Opportunities for Prevention. AIDS Behav (2015) 0.76
Beyond Risk Compensation: Clusters of Antiretroviral Treatment (ART) Users in Sexual Networks Can Modify the Impact of ART on HIV Incidence. PLoS One (2016) 0.75
Factors associated with changes in uptake of HIV testing among young women (aged 15-24) in Tanzania from 2003 to 2012. Infect Dis Poverty (2016) 0.75
Estimating the impact of universal antiretroviral therapy for HIV serodiscordant couples through home HIV testing: insights from mathematical models. J Int AIDS Soc (2016) 0.75
How do HIV-negative individuals in sub-Saharan Africa change their sexual risk behaviour upon learning their serostatus? A systematic review. Sex Transm Infect (2016) 0.75
Critical considerations for adopting the HIV 'treat all' approach in Zimbabwe: is the nation poised? Public Health Action (2016) 0.75
Switch from 200 to 350 CD4 baseline count: what it means to HIV care and treatment programs in Kenya. Pan Afr Med J (2012) 0.75
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS (2009) 11.62
Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy. AIDS (2009) 10.84
Concurrent partnerships and the spread of HIV. AIDS (1997) 10.73
Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet (2002) 7.64
Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med (2008) 7.49
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet (2006) 7.17
HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57
Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet (2008) 5.93
Public health. Reassessing HIV prevention. Science (2008) 4.06
Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med (2009) 4.05
Voluntary counselling and testing: uptake, impact on sexual behaviour, and HIV incidence in a rural Zimbabwean cohort. AIDS (2007) 3.54
Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32
Coming to terms with complexity: a call to action for HIV prevention. Lancet (2008) 3.15
Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med (2007) 2.56
HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res (2007) 2.55
Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52
Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sex Transm Infect (2008) 2.49
HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe. AIDS (2007) 2.15
Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics (2009) 2.05
Adverse effects of antiretroviral therapy for HIV infection. CMAJ (2004) 2.04
Risks of acquiring and transmitting sexually transmitted diseases in sexual partner networks. Sex Transm Dis (2000) 2.00
Treating our way out of the HIV pandemic: could we, would we, should we? Lancet (2008) 1.78
Beer halls as a focus for HIV prevention activities in rural Zimbabwe. Sex Transm Dis (2005) 1.72
Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.71
Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol (2008) 1.71
Prevalence of HIV among truck drivers visiting sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis (2002) 1.66
Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up. AIDS (2009) 1.62
Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav (2009) 1.41
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.23
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.06
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.05
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.05
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.04
Interpreting declines in HIV prevalence: impact of spatial aggregation and migration on expected declines in prevalence. Sex Transm Infect (2008) 1.02
Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 0.99
The role of testing and counselling for HIV prevention and care in the era of scaling-up antiretroviral therapy. Epidemics (2009) 0.99
Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol (2007) 0.98
HIV decline associated with behavior change in eastern Zimbabwe. Science (2006) 6.98
Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet (2002) 5.21
Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS (2003) 4.87
HIV and risk environment for injecting drug users: the past, present, and future. Lancet (2010) 4.77
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One (2010) 3.38
Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32
HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol (2010) 2.96
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science (2006) 2.76
Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe. Sex Transm Dis (2004) 2.75
Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy. PLoS Med (2006) 2.70
Modelling the impact of migration on the HIV epidemic in South Africa. AIDS (2007) 2.63
Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52
The theoretical population-level impact of a prophylactic human papilloma virus vaccine. Epidemiology (2002) 2.49
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31
A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med (2011) 2.23
Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet (2004) 2.20
Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage. Bull World Health Organ (2006) 2.20
Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med (2006) 2.10
Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm. AIDS (2011) 2.10
Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05
Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics (2009) 2.05
Prevalences of sexually transmitted infections in young adults and female sex workers in Peru: a national population-based survey. Lancet Infect Dis (2012) 2.03
Back to basics in HIV prevention: focus on exposure. BMJ (2003) 1.99
Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav (2011) 1.95
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. AIDS (2013) 1.88
The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS (2013) 1.81
Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. Sex Transm Infect (2012) 1.81
Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet (2012) 1.80
Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV (2015) 1.77
The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol (2005) 1.76
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med (2013) 1.73
Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example. J Infect Dis (2005) 1.71
Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One (2009) 1.62
Clandestine induced abortion: prevalence, incidence and risk factors among women in a Latin American country. CMAJ (2009) 1.55
Sex with stitches: assessing the resumption of sexual activity during the postcircumcision wound-healing period. AIDS (2012) 1.54
HIV incidence in 3 years of follow-up of a Zimbabwe cohort--1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol (2008) 1.54
Age at first sex and HIV infection in rural Zimbabwe. Stud Fam Plann (2007) 1.53
Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom. Vaccine (2009) 1.45
HIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV prevention. PLoS Med (2012) 1.45
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models. AIDS (2013) 1.42
Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -2003). Bull World Health Organ (2006) 1.42
Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav (2009) 1.41
The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study. PLoS Med (2012) 1.35
The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med (2008) 1.32
Individual level injection history: a lack of association with HIV incidence in rural Zimbabwe. PLoS Med (2005) 1.28
Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One (2008) 1.27
Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One (2013) 1.26
Appropriate evaluation of HIV prevention interventions: from experiment to full-scale implementation. Sex Transm Infect (2007) 1.26
Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS (2012) 1.26
Who is getting Pap smears in urban Peru? Int J Epidemiol (2008) 1.19
Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One (2013) 1.17
Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ (2012) 1.14
Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study. PLoS One (2013) 1.11
The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface (2012) 1.10
Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa. AIDS (2013) 1.10
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08
Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates. AIDS (2014) 1.06
The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS (2014) 1.01
Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination. PLoS One (2012) 1.00
HIV-1 prevention with ART and PrEP: mathematical modeling insights into resistance, effectiveness, and public health impact. J Infect Dis (2013) 1.00
HIV treatment as prevention: principles of good HIV epidemiology modelling for public health decision-making in all modes of prevention and evaluation. PLoS Med (2012) 0.99
Reaching the unreachable: providing STI control services to female sex workers via mobile team outreach. PLoS One (2013) 0.97
Is HIV out of control in the UK? An example of analysing patterns of HIV spreading using incidence-to-prevalence ratios. AIDS (2006) 0.97
Development and future directions for the Joint United Nations Programme on HIV/AIDS estimates. AIDS (2014) 0.96
Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sex Transm Infect (2010) 0.95
Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands. PLoS One (2013) 0.94
HPV-16 infection and cervical cancer: modeling the influence of duration of infection and precancerous lesions. Epidemics (2010) 0.93
Evidence for changes in behaviour leading to reductions in HIV prevalence in urban Malawi. Sex Transm Infect (2011) 0.92
The role of sexually transmitted infections in male circumcision effectiveness against HIV--insights from clinical trial simulation. Emerg Themes Epidemiol (2006) 0.90
Incorporating incidence information within the UNAIDS Estimation and Projection Package framework: a study based on simulated incidence assay data. AIDS (2014) 0.89
HIV-contaminated syringes are not evidence of transmission. AIDS (2006) 0.87
Estimating the range of potential epidemiological impact of pre-exposure prophylaxis: run-away success or run-away failure? AIDS (2015) 0.87
Estimating HIV incidence from case-report data: method and an application in Colombia. AIDS (2014) 0.85
Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey. Clin Infect Dis (2013) 0.85
Improved STD syndrome management by a network of clinicians and pharmacy workers in Peru: The PREVEN Network. PLoS One (2012) 0.85
Sexual risk among orphaned adolescents: is country-level HIV prevalence an important factor? AIDS Care (2010) 0.84
Vaccinating women previously exposed to human papillomavirus: a cost-effectiveness analysis of the bivalent vaccine. PLoS One (2013) 0.82
Antigen-driven T-cell turnover. J Theor Biol (2002) 0.81
Analytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectiveness. PLoS One (2013) 0.81
Notions of synergy for combinations of interventions against infectious diseases in heterogeneously mixing populations. Math Biosci (2010) 0.81
How much infertility does chlamydia cause? Sex Transm Infect (2008) 0.81
Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa. AIDS (2014) 0.79
Developments in the field of HIV estimates: methods, parameters and trends. Sex Transm Infect (2012) 0.79
Condom use by female sex workers and their clients in Mexico: who decides and does it matter? Sex Transm Infect (2011) 0.76
Could we, should we? Yes. AIDS (2011) 0.76
Let it be sexual--selection, aggregation and distortion used to construct a case against sexual transmission. Int J STD AIDS (2003) 0.76
Theory is critical in understanding the risks of acquiring HIV. Sex Transm Dis (2007) 0.76
Putting the burden of HIV in context. AIDS (2013) 0.75
Individual freedom versus collective responsibility: too many rights make a wrong? Emerg Themes Epidemiol (2006) 0.75
What might be the impact of sexual partnership "concurrency" behavior change communication campaigns? Sex Transm Dis (2012) 0.75
Inferring mechanisms for sexual partnership formation from the distribution of sexual partner numbers. Sex Transm Dis (2008) 0.75
Does nonlocal women's attendance at antenatal clinics distort HIV prevalence surveillance estimates in pregnant women in Zimbabwe? AIDS (2017) 0.75
Consequences of a changing US strategy in the global HIV investment landscape. AIDS (2017) 0.75
The influence of constraints on the efficient allocation of resources for HIV prevention: authors' response. AIDS (2019) 0.75
Editorial: methodological developments in the Joint United Nations Programme on HIV/AIDS estimates. AIDS (2017) 0.75
Mathematical modelling of the epidemiology of tuberculosis. Adv Exp Med Biol (2010) 0.75